Mediwound receives positive scientific advice from european medicine agency (ema) on escharex phase iii study design

Affirms the clear path forward for the company's global phase iii study of escharex in venous leg ulcers affirms the clear path forward for the company's global phase iii study of escharex in venous leg ulcers
MDWD Ratings Summary
MDWD Quant Ranking